麻醉诱导的海马-皮层过活和陶过酸化会损害阿尔茨海默病中远程记忆检索
Kai Chen1, Riya Gupta2, Alejandro Martín-Ávila3
1Department of Anesthesiology, Columbia University Irving Medical Center, New York, New York, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|September 11, 2023
概括
麻醉使阿尔茨海默病 (AD) 的记忆丧失恶化,因为它会导致大脑过度活跃. 向陶过酸化可能会在阿兹海默症患者中预防这种记忆障碍.
科学领域:
- 神经科学是一个神经科学.
- 阿尔茨海默氏症疾病研究研究
- 麻醉学 麻醉学
背景情况:
- 麻醉可以使阿尔茨海默病 (AD) 患者的记忆回忆缺陷恶化.
- 在AD中麻醉诱导的记忆障碍背后的精确机制尚未完全理解.
研究的目的:
- 在前症状阿尔茨海默氏病的小鼠模型中调查麻醉诱导的远程记忆障碍背后的神经机制.
- 确定潜在的治疗目标,以减轻与阿尔茨海默病麻醉相关的记忆缺陷.
主要方法:
- 用于体内成像,基于病毒的电路跟踪和化学遗传学.
- 检查了前症状阿尔茨海默病的小鼠模型.
主要成果:
- 确定前带带皮质 (ACC) 中的金字塔神经元过度活跃是麻醉引起的记忆障碍的关键因素.
- 局部抑制电路的抑制和海马的CA1输入增加有助于ACC过度激活.
- 在海马体中抑制CA1-ACC电路过活和高酸化改善了记忆回忆缺陷和神经功能障碍.
结论:
- 海马-皮层过度活动与阿尔茨海默病中麻醉诱导的远程记忆障碍有关.
- 向陶过酸化是一种有前途的治疗策略,可以抵消麻醉引起的神经网络功能障碍和阿尔茨海默病的逆行性失忆症.
更多相关视频
14:57Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology
Published on: March 23, 2011
94.2K
07:07Analysis of Learning and Memory Ability in an Alzheimer's Disease Mouse Model using the Morris Water Maze
Published on: October 29, 2019
19.2K
相关概念视频
Alzheimer's Disease: Overview
517
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
517
Role of Hippocampus in Memory
305
The hippocampus, a critical brain structure, plays an essential role in memory processing, particularly in the formation and retrieval of memory. This small, seahorse-shaped region is located within the medial temporal lobe, with one hippocampus in each brain hemisphere. Experimental studies involving lesions in the hippocampi of rats have demonstrated significant impairments in tasks such as object recognition and maze navigation, indicating the hippocampus involvement in both recognition and...
305
Alzheimer's Disease: Treatment
212
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
151
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
151
Amnesia
153
Amnesia is a condition marked by long-term memory loss, which impairs the ability to recall past events or create new memories.
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
153
Long-term Depression
2.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.6K
